The results revealed that total protein expression of CCNB1 was elevated in nine types of cancer, including breast cancer, GBM, HNSC, hepatocellular carcinoma, LUAD, LUSC, ovarian cancer, UCEC, and PAAD (Figure 2). This evidence concerns the gene CCNB1 and pancreatic adenocarcinoma.